Free Trial

CareDx (CDNA) Competitors

CareDx logo
$11.91 +0.10 (+0.85%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$12.10 +0.20 (+1.64%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CDNA vs. RDNT, BTSG, SHC, SGRY, CON, PRVA, WGS, VCYT, ARDT, and ADUS

Should you be buying CareDx stock or one of its competitors? The main competitors of CareDx include RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Ardent Health (ARDT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry.

CareDx vs. Its Competitors

RadNet (NASDAQ:RDNT) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

CareDx has a net margin of 19.79% compared to RadNet's net margin of -1.73%. CareDx's return on equity of 21.16% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-1.73% 1.41% 0.48%
CareDx 19.79%21.16%14.25%

77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 4.4% of CareDx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, CareDx had 1 more articles in the media than RadNet. MarketBeat recorded 10 mentions for CareDx and 9 mentions for RadNet. RadNet's average media sentiment score of 0.89 beat CareDx's score of 0.19 indicating that RadNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareDx
2 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareDx has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than CareDx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$1.83B2.36$2.79M-$0.43-133.70
CareDx$333.79M1.99$52.55M$1.1510.36

RadNet presently has a consensus target price of $69.60, suggesting a potential upside of 21.06%. CareDx has a consensus target price of $29.33, suggesting a potential upside of 146.29%. Given CareDx's higher possible upside, analysts clearly believe CareDx is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
3 Strong Buy rating(s)
3.50
CareDx
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500. Comparatively, CareDx has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500.

Summary

CareDx beats RadNet on 10 of the 17 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDNA vs. The Competition

MetricCareDxMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$663.15M$6.88B$5.51B$9.40B
Dividend YieldN/A2.92%4.00%4.04%
P/E Ratio10.3627.3428.1919.77
Price / Sales1.9936.67417.6388.88
Price / Cash8.7629.7324.9928.17
Price / Book1.699.028.155.69
Net Income$52.55M$236.06M$3.25B$257.97M
7 Day Performance-40.51%-1.30%0.42%1.92%
1 Month Performance-37.45%2.71%7.76%12.82%
1 Year Performance-34.16%23.48%33.64%19.22%

CareDx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDNA
CareDx
4.1624 of 5 stars
$11.91
+0.8%
$29.33
+146.3%
-34.2%$663.15M$333.79M10.36740Analyst Forecast
Gap Up
High Trading Volume
RDNT
RadNet
3.7133 of 5 stars
$56.59
+2.0%
$69.60
+23.0%
-7.3%$4.25B$1.87B-131.6011,021
BTSG
BrightSpring Health Services
1.9633 of 5 stars
$20.31
flat
$24.90
+22.6%
+70.4%$3.57B$11.86B72.5435,000
SHC
Sotera Health
3.1229 of 5 stars
$11.61
-1.6%
$16.00
+37.8%
-15.5%$3.30B$1.10B145.143,000News Coverage
Positive News
SGRY
Surgery Partners
2.8552 of 5 stars
$22.47
+2.0%
$33.56
+49.3%
-23.2%$2.88B$3.11B-14.6915,000
CON
Concentra Group Holdings Parent
2.996 of 5 stars
$20.23
+1.6%
$28.50
+40.9%
N/A$2.59B$1.90B15.0911,250
PRVA
Privia Health Group
3.9381 of 5 stars
$20.89
+2.1%
$28.38
+35.9%
+2.3%$2.55B$1.80B174.101,140Positive News
WGS
GeneDx
3.8477 of 5 stars
$82.39
-0.2%
$92.33
+12.1%
+144.6%$2.35B$330.14M-58.431,200
VCYT
Veracyte
3.7663 of 5 stars
$26.65
-1.6%
$40.90
+53.5%
+1.4%$2.09B$445.76M65.00790
ARDT
Ardent Health
3.3833 of 5 stars
$14.51
+2.4%
$20.67
+42.4%
-35.5%$2.08B$5.97B8.9024,900
ADUS
Addus HomeCare
4.9746 of 5 stars
$111.75
+0.7%
$142.57
+27.6%
-9.9%$2.06B$1.15B25.2349,703Positive News

Related Companies and Tools


This page (NASDAQ:CDNA) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners